USA Patent Number 9,821,031, 2017
Practical supports are the ones that let you detect change early: Frequent weight checks Simple glucose logs if relevant Short follow-up visits in the first few weeks Clinicians may discuss alternative options such as different GLP-1 agents or combination therapies if weight or glucose control slips
Journal of Peptide Science, 30 (11), Article e3627
This effect is part of the entero-insular axis of glucose homeostasis and is estimated to be responsible for at least 50% of insulin secretion [2, 3]
No affiliation with Eli Lilly and Company, the only US source of FDA-approved tirzepatide
This study aimed to uncover the changes in physicians perceptions from before to after oral semaglutide initiation in respect to adherence to the dosing requirements for oral semaglutide